R
Renaissance Research and Medical Group | Cape Coral, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
PF-04965842
Rocatinlimab
Dupilumab
PF-07038124
Amlitelimab
PF-07264660
AMG 451
Fezolinetant
Camoteskimab
SAR441566
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 13 total trials
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab
The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...
Enrolling
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo
This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD).The purpose of thi...
Enrolling
Dermatitis Atopic
Drug: Amlitelimab
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems